These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 7561379)
21. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917 [TBL] [Abstract][Full Text] [Related]
22. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction. Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971 [TBL] [Abstract][Full Text] [Related]
23. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Li Y; Takemura G; Kosai K; Takahashi T; Okada H; Miyata S; Yuge K; Nagano S; Esaki M; Khai NC; Goto K; Mikami A; Maruyama R; Minatoguchi S; Fujiwara T; Fujiwara H Circ Res; 2004 Sep; 95(6):627-36. PubMed ID: 15297380 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling. Kramer CM; Ferrari VA; Rogers WJ; Theobald TM; Nance ML; Axel L; Reichek N J Am Coll Cardiol; 1996 Jan; 27(1):211-7. PubMed ID: 8522697 [TBL] [Abstract][Full Text] [Related]
25. Effect of angiotensin-converting enzyme inhibitors in left ventricular dysfunction: results of the studies of left ventricular dysfunction in the context of other similar trials. Yusuf S; Garg R; McConachie D J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S28-35. PubMed ID: 7514238 [TBL] [Abstract][Full Text] [Related]
26. [Myocardial fibrosis--the theoretical bases, clinical aspects and therapeutic implications]. Perdigão C Rev Port Cardiol; 1993; 12(7-8):675-85, 603. PubMed ID: 8352988 [TBL] [Abstract][Full Text] [Related]
27. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study. Ferrari R; Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606 [TBL] [Abstract][Full Text] [Related]
28. New concepts in post-infarction ventricular remodeling. Udelson JE; Patten RD; Konstam MA Rev Cardiovasc Med; 2003; 4 Suppl 3():S3-12. PubMed ID: 14564229 [TBL] [Abstract][Full Text] [Related]
29. Invited commentary. Dixon IM Ann Thorac Surg; 2009 Dec; 88(6):1921-2. PubMed ID: 19932263 [No Abstract] [Full Text] [Related]
30. [Physiopathology of left ventricular remodeling after myocardial infarction]. Bassand JP; Anguenot T Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():43-9. PubMed ID: 1838920 [TBL] [Abstract][Full Text] [Related]
31. Increased circulating concentrations and augmented myocardial extraction of osteoprotegerin in heart failure due to left ventricular pressure overload. Helske S; Kovanen PT; Lindstedt KA; Salmela K; Lommi J; Turto H; Werkkala K; Kupari M Eur J Heart Fail; 2007 Apr; 9(4):357-63. PubMed ID: 17254844 [TBL] [Abstract][Full Text] [Related]
32. Usefulness of left ventricular dyssynchrony after acute myocardial infarction, assessed by a tagging magnetic resonance image derived metric, as a determinant of ventricular remodeling. Chang SA; Chang HJ; Choi SI; Chun EJ; Yoon YE; Kim HK; Kim YJ; Choi DJ; Sohn DW; Helm RH; Lardo AC Am J Cardiol; 2009 Jul; 104(1):19-23. PubMed ID: 19576315 [TBL] [Abstract][Full Text] [Related]
33. [Neurohumoral activation and remodeling after acute myocardial infarct and the effect of angiotensin-converting enzyme inhibitors]. Dúbrava J; Cagán S Bratisl Lek Listy; 1993 Feb; 94(2):88-93. PubMed ID: 8102588 [TBL] [Abstract][Full Text] [Related]
34. [Indications for ACE inhibitors in the postinfarct period]. Ertl G; Gaudron P; Neubauer S; Hu K; Zdrojewski T; Horn M; Kochsiek K Z Kardiol; 1994; 83 Suppl 4():65-74. PubMed ID: 7856283 [TBL] [Abstract][Full Text] [Related]
35. Early, selective growth hormone administration may ameliorate left ventricular remodeling after myocardial infarction. Mitsi AC; Hatzistergos K; Baltogiannis GG; Kolettis TM Med Hypotheses; 2005; 64(3):582-5. PubMed ID: 15617872 [TBL] [Abstract][Full Text] [Related]
36. [Effect of lisinopril on cardiac remodeling in patients with cardiosclerosis after myocardial infarction and signs of chronic heart failure]. Blagodar VN; Petriĭ VV; Makolkin VI Kardiologiia; 2003; 43(9):17-20. PubMed ID: 14682288 [No Abstract] [Full Text] [Related]
37. Patterns of ventricular remodeling after myocardial infarction: clues toward linkage between mechanism and morbidity. Konstam MA JACC Cardiovasc Imaging; 2008 Sep; 1(5):592-4. PubMed ID: 19356486 [No Abstract] [Full Text] [Related]
38. Ventricular remodeling. Mechanisms and prevention. Goldstein S; Ali AS; Sabbah H Cardiol Clin; 1998 Nov; 16(4):623-32, vii-viii. PubMed ID: 9891592 [TBL] [Abstract][Full Text] [Related]
40. The pathophysiologic process of ventricular remodeling: from infarct to failure. Paul S Crit Care Nurs Q; 1995 May; 18(1):7-21. PubMed ID: 7719950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]